Paydirt
CP
Insider

Christopher Peetz

CHIEF EXECUTIVE OFFICER · Mirum Pharmaceuticals

Christopher Peetz (CHIEF EXECUTIVE OFFICER) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $3.8M of MIRM (40,985 sh × $91.98, as filed), executed Mar 16. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$18.0M
shares × price, as filed
Last traded
Nov 4
Filed Nov 4

Median ADV $83.1M across their filed names

Open performance→
Volume by month
$4.7M$2.3M$0Dec 2024Jun 2025Dec 2025Jun 2026Jan 2025 · sells $648KFeb 2025 · sells $439KMar 2025 · sells $3.1MAug 2025 · sells $4.7MJan 2026 · sells $1.3MFeb 2026 · sells $941KMar 2026 · sells $3.8MJun 2026 · sells $2.8MJul 2026 · sells $2.4MAug 2026 · sells $2.0MSep 2026 · sells $3.0MNov 2026 · sells $1.8M
Buys $0 Sells $26.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 9 filings

Sector per market data · by filing · past 12 months

Most traded names
MIRM Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 16 sells 16 filings
Recent filings
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $662K
7,098 sh × $93.33
Exec Jan 22
Filed Jan 23 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.5M
40,000 sh × $62.00
Exec Aug 11 2025
Filed Aug 12 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $2.2M
40,000 sh × $55.25
Exec Aug 7 2025
Filed Aug 8 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.2M
27,279 sh × $44.21
Exec Mar 17 2025
Filed Mar 18 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $1.9M
40,000 sh across 2 lots
Exec Mar 3 2025
Filed Mar 4 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $439K
9,102 sh × $48.22
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $328K
6,837 sh × $47.92
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $321K
7,489 sh × $42.82
Exec Jan 7 2025
Filed Jan 8 2025 · 5:30 PM ET